| 27/08/26 | 07:00:00 | 27 Aug 2026 | | hVIVO acquires CRS Berlin, expanding expertise into dermatology and women's health markets | GNW |
| 08/01/24 | 07:00:04 | 8 Jan 2024 | | Broker change | RNS |
| 02/01/24 | 07:00:04 | 2 Jan 2024 | | £6.3m HRV contract signed with biotech client | RNS |
| 13/12/23 | 07:00:10 | 13 Dec 2023 | | £16.8m RSV contract & Trading ahead of guidance | RNS |
| 05/10/23 | 07:00:06 | 5 Oct 2023 | | Positive results from flu human challenge study | RNS |
| 12/09/23 | 07:00:03 | 12 Sept 2023 | | Interim results | RNS |
| 01/09/23 | 07:00:04 | 1 Sept 2023 | | Exercise of Warrants | RNS |
| 29/08/23 | 07:00:05 | 29 Aug 2023 | | Plans for a new larger state-of-the-art facility | RNS |
| 24/08/23 | 07:00:05 | 24 Aug 2023 | | Notice of Results | RNS |
| 26/07/23 | 07:00:05 | 26 Jul 2023 | | Trading update | RNS |
| 25/07/23 | 07:00:06 | 25 Jul 2023 | | Flu B challenge model | RNS |
| 28/06/23 | 07:00:03 | 28 Jun 2023 | | hMPV human challenge model | RNS |
| 14/06/23 | 08:00:01 | 14 Jun 2023 | | Director dealings | RNS |
| 23/05/23 | 12:36:08 | 23 May 2023 | | Result of AGM | RNS |
| 28/04/23 | 07:00:09 | 28 Apr 2023 | | Annual Report and Notice of AGM | RNS |
| 26/04/23 | 07:00:11 | 26 Apr 2023 | | FDA Breakthrough and Fast Track for US biotech | RNS |
| 25/04/23 | 07:00:07 | 25 Apr 2023 | | Final results | RNS |
| 19/04/23 | 07:10:55 | 19 Apr 2023 | | Notice of Results | RNS |
| 06/04/23 | 15:54:40 | 6 Apr 2023 | | Holding(s) in Company | RNS |
| 03/04/23 | 07:00:17 | 3 Apr 2023 | | Positive results from flu human challenge study | RNS |
| 29/03/23 | 07:00:06 | 29 Mar 2023 | | Presentation at World Vaccine Congress | RNS |
| 23/03/23 | 07:00:03 | 23 Mar 2023 | | Exercise of Options | RNS |
| 16/03/23 | 07:00:05 | 16 Mar 2023 | | Omicron human challenge model update | RNS |
| 06/02/23 | 09:05:52 | 6 Feb 2023 | | Second Price Monitoring Extn | RNS |
| 06/02/23 | 09:00:35 | 6 Feb 2023 | | Price Monitoring Extension | RNS |
| 06/02/23 | 07:05:01 | 6 Feb 2023 | | Long Term Incentive Plan / PDMR Notification | RNS |
| 06/02/23 | 07:00:02 | 6 Feb 2023 | | £6.8m RSV human challenge contract signed | RNS |
| 25/01/23 | 09:06:01 | 25 Jan 2023 | | Second Price Monitoring Extn | RNS |
| 25/01/23 | 09:00:31 | 25 Jan 2023 | | Price Monitoring Extension | RNS |
| 25/01/23 | 07:00:04 | 25 Jan 2023 | | Trading update | RNS |
| 17/01/23 | 07:00:06 | 17 Jan 2023 | | EUR3.2m Venn contract with global pharma client | RNS |
| 04/01/23 | 16:40:55 | 4 Jan 2023 | | Second Price Monitoring Extn | RNS |
| 04/01/23 | 16:35:31 | 4 Jan 2023 | | Price Monitoring Extension | RNS |
| 04/01/23 | 07:00:03 | 4 Jan 2023 | | £5.2m RSV contract and Notice of Trading update | RNS |
| 03/01/23 | 16:40:17 | 3 Jan 2023 | | Second Price Monitoring Extn | RNS |
| 03/01/23 | 16:35:15 | 3 Jan 2023 | | Price Monitoring Extension | RNS |
| 03/01/23 | 14:05:48 | 3 Jan 2023 | | Second Price Monitoring Extn | RNS |
| 03/01/23 | 14:00:29 | 3 Jan 2023 | | Price Monitoring Extension | RNS |
| 03/01/23 | 11:05:22 | 3 Jan 2023 | | Second Price Monitoring Extn | RNS |
| 03/01/23 | 11:00:10 | 3 Jan 2023 | | Price Monitoring Extension | RNS |
| 19/12/22 | 07:00:08 | 19 Dec 2022 | | Imutex Phase I data published | RNS |
| 17/11/22 | 14:05:53 | 17 Nov 2022 | | Second Price Monitoring Extn | RNS |
| 17/11/22 | 14:00:38 | 17 Nov 2022 | | Price Monitoring Extension | RNS |
| 11/11/22 | 07:00:06 | 11 Nov 2022 | | Exercise of Options | RNS |
| 10/11/22 | 11:00:48 | 10 Nov 2022 | | Price Monitoring Extension | RNS |
| 10/11/22 | 08:22:04 | 10 Nov 2022 | | £13.6m RSV antiviral contract | RNS |
| 04/11/22 | 07:25:43 | 4 Nov 2022 | | Holding(s) in Company | RNS |
| 25/10/22 | 07:00:06 | 25 Oct 2022 | | Change of name to hVIVO plc effective | RNS |
| 20/10/22 | 07:00:04 | 20 Oct 2022 | | Capital Markets Day | RNS |
| 18/10/22 | 07:00:06 | 18 Oct 2022 | | CFO appointment & change of Board roles | RNS |
